Taconic Capital Advisors’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Taconic Capital Advisors’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100,000	Closed	-$1.9K	–	300
2023 Q1	$1.9K	Hold	100,000	–	–	﹤0.01%	286
2022 Q4	$14.9K	Hold	100,000	–	–	﹤0.01%	401
2022 Q3	$17K	Hold	100,000	–	–	﹤0.01%	536
2022 Q2	$13K	Hold	100,000	–	–	﹤0.01%	638
2022 Q1	$79K	Hold	100,000	–	–	﹤0.01%	505
2021 Q4	$60K	Hold	100,000	–	–	﹤0.01%	503
2021 Q3	$95K	Hold	100,000	–	–	﹤0.01%	391
2021 Q2	$140K	Buy	+100,000	New	+$87.3K	﹤0.01%	394

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Taconic Capital Advisors's PEARW Position: Q2 2023 in Review

Taconic Capital Advisors sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 100,000 shares — an estimated $1.9K sold.

Taconic Capital Advisors first reported a position in PEARW in Q2 2021 and held it in 8 quarters. The position peaked at $140K in Q2 2021. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Taconic Capital Advisors reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Taconic Capital Advisors sold 100,000 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $1.9K.
Taconic Capital Advisors first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and held it in 8 quarters.
Taconic Capital Advisors's Pear Therapeutics, Inc. Warrant position peaked at $140K in Q2 2021.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Taconic Capital Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.